Search results
Body
Showing 211-220 of 945 results
ISCHEMIA trial outcomes found a significant benefit in quality of life and patient experience.
A therapy on the horizon could be the first to specifically treat the underlying cause of hypertrophic cardiomyopathy.
Learn more about Saint Luke's Health System's awards and recognition.
November is lung cancer awareness month. A local man is working to raise awareness and change perceptions here in Kansas City.
Whites are three times more likely to survive a cardiac arrest after receiving bystander CPR than Black adults are, a new study has found.
Semaglutide cut the risk for worsening heart failure and cardiovascular death for adults with heart failure with preserved ejection fraction, according to new data presented by Dr. Mikhail Kosiborod.
Our bereavement coordinators are available to help you maneuver through the difficult terrain ahead.
Did you know? Heart disease is the number one health threat for women with an estimated 43.8 million women living with or at risk for cardiovascular disease.
T32 grant funding trains next generation of leaders in clinical and outcomes research
Deborah Sandler Kemper's back pain was unbearable. After seeking expertise from Saint Luke's Marion Bloch Neuroscience Institute, she has returned to her active lifestyle with no pain.